Latest Announcements

Sri Havisha Hospitality and Infrastructure Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the acceptance or rejection of securities received for dematerialization during the quarter ended 30th September, 2026.

Sri Havisha Hospitality And Infrastructure Ltd has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities and listing on stock exchanges.

Aashka Hospitals Ltd has issued a clarification letter to BSE regarding significant price movement in its script, stating that the movement is market-driven and the company has no control or knowledge of the reasons.

Chennai Petroleum Corporation Ltd has filed a compliance certificate under Regulation 74(5) of SEBI (DP) regulations, 2018 for the quarter ended 30.09.2026, confirming the company's compliance with the provisions of the regulation.

NLC India Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the listing of dematerialized shares, cancellation of mutilated certificates, and furnishing of dematerialization/rematerialization details to stock exchanges.

Transgene Biotek Ltd has confirmed that it does not fall under the category of 'Large Corporate' as per SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, and BSE Circular No. LIST/COM/05/2019-20 dated April 11, 2019.

Pace Digitek Limited has responded to the National Stock Exchange's (NSE) query regarding a significant increase in volume of its shares, stating that the company is in compliance with SEBI listing regulations and has made all necessary disclosures.

Dr. Reddy's Laboratories Limited has informed the Exchange about imposition of a penalty of $32,350.20 to its step-down wholly owned subsidiary, Dr. Reddy's Laboratories, Inc., due to misclassification of Fiscal year reference at the time of tax payment.

KSS Ltd has been granted a two-month extension for holding its Annual General Meeting (AGM) for the financial year ended 31st March, 2026, due to unforeseen circumstances.

Dr Reddys Laboratories Ltd has received a penalty of $32,350.20 from the US Internal Revenue Service for misclassifying a fiscal year reference at the time of tax payment. The company states that there is no material impact on its financials, operations, or other activities.

Emrock Corporation Ltd has confirmed that it has not issued any non-convertible securities during the second quarter ended on 30th September, 2026, making the provision of Regulation 57(5) of SEBI (LODR) Regulations, 2015, not applicable.

S. M. Gold Ltd has responded to BSE's request for clarification on the significant movement in the price of its shares, stating that the movement is market-driven and that the company has made all necessary disclosures.

SMC Global Securities Ltd has been fined Rs 1,00,000 by SEBI for non-compliance with regulations related to client order placement and supervision of Authorized Persons.

SMC Global Securities Limited has been fined Rs. 1,00,000 by SEBI for non-compliance with SEBI (Stock Brokers) Regulations, 1992 and circulars issued by SEBI and NSE.

NPR Finance Ltd has published a newspaper notice regarding the closure of its branch office at Kolkata, effective January 1, 2027, due to a home loan default. The company will continue to operate from its registered office.

Bank of Maharashtra has issued a certificate confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30.09.2026.

Balurghat Technologies Ltd clarifies that the recent price movement in its shares is due to market conditions and not due to any material information withheld by the company.

Jhandewalas Foods Ltd has responded to a clarification sought by the Bombay Stock Exchange regarding significant movement in the company's share price, stating that the movement is market-driven and the company is not aware of any specific reason for it.

Medplus Health Services Ltd has issued a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, for the quarter ended September 30, 2026, certifying that the details of securities dematerialized/rematerialized have been furnished to all the stock exchanges where the company's shares are listed.

Amkay Products Ltd clarified to BSE that the company has been disclosing all price-sensitive information as required under SEBI (LODR) Regulations 2015, and the movement in the company's share price is due to market conditions.